CDC's Answers On Merck's Hib Vaccine Recall
Merck's voluntary Hib vaccine recall raises many questions. CDC provides information for public health agencies and healthcare providers about Merck's recall of certain lots of Haemophilus influenza type b (Hib) vaccine.
Last month, Merck & Co., Inc. reported that their PedvaxHIB vaccine would be unavailable for shipment pending the results of production quality tests. At that time, Merck expected PedvaxHIB to be available some time in the first quarter of 2008, but reported that the exact timing would be dependent on resolution of a manufacturing issue. On December 13, Merck & Co. will announce that it has initiated a voluntary recall in the United States for certain lots of PedvaxHIB